Drug Profile


Alternative Names: Corlopam; SKF 82526; SKF 82526J

Latest Information Update: 13 Apr 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Developer Elan Pharmaceuticals; GlaxoSmithKline
  • Class Antihypertensives; Benzazepines; Small molecules
  • Mechanism of Action Dopamine D1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Hypertension; Malignant hypertension; Perioperative hypertension
  • Discontinued Diabetes mellitus; Heart failure; Renal failure

Most Recent Events

  • 06 Aug 2013 Biomarkers information updated
  • 01 Oct 2004 Medeus Pharma is now called Zeneus Pharma
  • 10 Nov 2003 A study has been added to the Genitourinary Disorders therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top